[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
April 1988

Diameter, Cell Type, and Survival in Stage I Primary Non—Small-Cell Lung Cancer

Author Affiliations

From the Veterans Administration Medical Center and the University of Arkansas for Medical Sciences, Little Rock.

Arch Surg. 1988;123(4):446-449. doi:10.1001/archsurg.1988.01400280052010
Abstract

• We analyzed 384 veterans who had "curative" (sometimes conservative) resection from 1966 through 1986 for stage I, non—small-cell primary lung cancer to identify significant variables influencing survival. Operative mortality was 3.1%, mainly from heart attacks. Most patients were asymptomatic, presenting with other diseases of smoking. Five-year survival was 43%; deaths from lung cancer only, 63% (T1,73%; T2,49%). Two hundred fourteen (57.5%) of the 372 operative survivors had T1 and 158 (42.5%) had T2 disease. Sixty-five percent had peripheral nodules (84%, T1; 38% T2). Pure squamous cell predominated, in 63% overall (T1, 55%; T2, 74%). Systemic metastases caused most cancer deaths. Within T1, diameter was highly significant. Cell type and time of operation (before or after Dec 31, 1980) were also significant. Under T2, only scarring and differentiation were significant. Veterans in this group live longer if they have small squamous cell tumors.

(Arch Surg 1988;123:446-449)

References
1.
Steele JD, Kleitsch WP, Dunn JE Jr, et al:  Survival in males with bronchogenic carcinomas resected as asymptomatic solitary pulmonary nodules . Ann Thorac Surg 1966;2:368-376.Article
2.
Higgins GA, Shields TW, Keehn R:  The solitary pulmonary nodule: Ten-year follow-up of Veterans Administration—Armed Forces cooperative study . Arch Surg 1975;110:570-575.Article
3.
Williams DE, Pairolero PC, Davis CS, et al:  Survival of patients surgically treated for stage I lung cancer . J Thorac Cardiovasc Surg 1981;82:70-76.
4.
Mountain CF:  A new international staging system for lung cancer . Chest 1986;89( (suppl) ):225S-233S.Article
5.
Feld R, Rubinstein LV, Weisenberger TH:  Sites of recurrence in resected stage I non—small-cell lung cancer: A guide for future studies . J Clin Oncol 1984;2:1352-1358.
6.
Dixon WJ (ed): BMDP Manual . Los Angeles, University of California, 1983.
7.
Errett LE, Wilson J, Chiu RC, et al:  Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients . J Thorac Cardiovasc Surg 1985;90:656-661.
8.
Read RC:  Presidential address on systemic effects of smoking . Am J Surg 1984;148:706-711.Article
9.
Little AG, DeMeester TR, Ferguson MK:  Modified stage I (T1NOMO, T2NOMO), nonsmall cell lung cancer: Treatment results, recurrence patterns, and adjuvant immunotherapy . Surgery 1986;100:621-628.
10.
Matthews MJ:  Morphology of lung cancer . Semin Oncol 1974;1: 175-182.
11.
Cox JD, Yesner RA:  Adenocarcinoma of the lung: Recent results from the Veterans Administration Lung Group . Am Rev Respir Dis 1979;120: 1025-1029.
12.
Shimosato Y, Hashimoto T, Kodama T, et al:  Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers . Am J Surg Pathol 1980;4:365-373.Article
×